Phase II trial of SGE 102 in patients with refractory status epilepticus
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2016
At a glance
- Drugs Brexanolone (Primary) ; Midazolam
- Indications Status epilepticus
- Focus Therapeutic Use
- 03 Mar 2016 According to Sage Therapeutics media release, data presented at the. 68th American Academy of Neurology (AAN).
- 09 Jan 2015 Interim results in 9 evaluable patients published in a SAGE Therapeutics media release.
- 03 Nov 2014 Results in two paediatric patients published in a Sage Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History